[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Correction
May 12, 2004

Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)—Correction

JAMA. 2004;291(18):2196. doi:10.1001/jama.291.18.2196

Investigator Omitted: In the Original Contribution entitled "Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)" published in the December 18, 2002, issue of THE JOURNAL (2002;288:2981-2997), Pasquale F. Nestico, MD, was inadvertently omitted from the list of ALLHAT investigators. His name should appear on page 2996 under "Pennsylvania."

×